肾动脉化疗栓塞术治疗晚期肾癌的临床价值  

Clinical value of renal arterial chemoembolization in the treatment of advanced kidney cancer

作　　者：陈卫[1] 王煊[1] 黄加胜[1] 

机构地区：[1]南京医科大学附属淮安第一医院介入科,223300

出　　处：《中国实用医药》2016年第36期67-68,共2页China Practical Medicine

摘　　要：目的探索肾动脉化疗栓塞术治疗晚期肾癌的临床疗效。方法 7例经皮肾动脉化疗栓塞术治疗的晚期肾癌患者,使用碘化油乳剂行栓塞治疗。回顾性分析患者临床病例资料,观察化疗栓塞疗效。结果全部患者均成功施行介入手术,手术成功率100%。术后临床症状减轻,无明显并发症。随访时间2-19个月,术后1个月肿瘤缩小为（6.2±4.1）cm,与术前的（8.1±3.3）cm比较,差异有统计学意义（P〈0.05）。至末次随访时间存活3例（42.86%）,死亡4例,中位生存期13个月。结论晚期肾癌接受经皮肾动脉化疗栓塞术治疗安全有效,可以作为临床姑息治疗方法之一。Objective To explore clinical effect by renal arterial chemoembolization in the treatment of advanced kidney cancer. Methods A total of 7 patients with advanced kidney cancer received iodinated oil emulsion for renal arterial chemoembolization. Their clinical data were retrospectively analyzed, and chemoembolization effects were observed. Results All patients received successful intervention operation, with operation success rate as 100%. They had relieved clinical symptoms after operation, without obvious complications. Follow-up lasting for 2-19 months showed decreased tumor size as （6.2 ± 4.1） cm in 1 month after operation. Comparing with （8.1 ± 3.3） cm before operation, their difference had statistical significance （P〈0.05）. There were 3 survived cases （42.86%） and 4 death cases at final follow-up, with median survival time as 13 months. Conclusion Percutaneous renal arterial chemoembolization is safe and effective in treating advanced kidney cancer, and this method can be applied as one of clinical palliative treatment measures.

关 键 词：晚期肾癌 肾动脉化疗栓塞术 临床价值 

分 类 号：R737.11[医药卫生—肿瘤]